Antispasmodic Effect of Valeriana pilosa Root Essential Oil and Potential Mechanisms of Action: Ex Vivo and In Silico Studies

dc.contributor.affiliationUniversidad Nacional de Trujillo
dc.contributor.affiliationUniversidad Arturo Prat
dc.contributor.affiliationUniversidad Austral de Chile
dc.contributor.affiliationUniversidad Catolica Los Angeles De Chimbote
dc.contributor.affiliationUniversidad de Las Americas - Chile
dc.contributor.affiliationUniversidad Nacional de la Amazonia Peruana
dc.contributor.authorYbañez-Julca, Roberto
dc.contributor.authorPino-Rios, Ricardo
dc.contributor.authorQuispe-Diaz, Ivan
dc.contributor.authorAsunción-Alvarez, Daniel
dc.contributor.authorAcuña-Tarrillo, Edwin
dc.contributor.authorMantilla-Rodriguez, Elena
dc.contributor.authorMinchan-Herrera, Patricia
dc.contributor.authorCatalan, Marcelo
dc.contributor.authorZevallos-Escobar, Liz
dc.contributor.authorVasquez-Corales, Edison
dc.contributor.authorYáñez, Osvaldo
dc.contributor.authorGutierrez-Alvarado, Wilfredo
dc.contributor.authorBenites, Julio
dc.date.accessioned2024-09-03T19:17:39Z
dc.date.available2024-09-03T19:17:39Z
dc.date.issued2023-08-02
dc.description.abstractInfusions of Valeriana pilosa are commonly used in Peruvian folk medicine for treating gastrointestinal disorders. This study aimed to investigate the spasmolytic and antispasmodic effects of Valeriana pilosa essential oil (VPEO) on rat ileum. The basal tone of ileal sections decreased in response to accumulative concentrations of VPEO. Moreover, ileal sections precontracted with acetylcholine (ACh), potassium chloride (KCl), or barium chloride (BaCl2) were relaxed in response to VPEO by a mechanism that depended on atropine, hyoscine butylbromide, solifenacin, and verapamil, but not glibenclamide. The results showed that VPEO produced a relaxant effect by inhibiting muscarinic receptors and blocking calcium channels, with no apparent effect on the opening of potassium channels. In addition, molecular docking was employed to evaluate VPEO constituents that could inhibit intestinal contractile activity. The study showed that α-cubebene, β-patchoulene, β-bourbonene, β-caryophyllene, α-guaiene, γ-muurolene, valencene, eremophyllene, and δ-cadinene displayed the highest docking scores on muscarinic acetylcholine receptors and voltage-gated calcium channels, which may antagonize M2 and/or M3 muscarinic acetylcholine receptors and block voltage-gated calcium channels. In summary, VPEO has both spasmolytic and antispasmodic effects. It may block muscarinic receptors and calcium channels, thus providing a scientific basis for its traditional use for gastrointestinal disorders.
dc.description.sponsorshipProyecto Canon Minero (Peril) [0262-2021/UNT]; Fondo Interno VRII-UNAP (Chile) [VRIIP0056-21]; This research was funded by Proyecto Canon Minero (R.R. No 0262-2021/UNT, Peril), and Fondo Interno VRII-UNAP, grant number (VRIIP0056-21, Chile).
dc.format.mimetypeapplication/pdf
dc.identifier.citationPharmaceutics, 15(8), 2072. https://doi.org/10.3390/pharmaceutics15082072
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics15082072
dc.identifier.issn1999-4923
dc.identifier.orcidhttps://orcid.org/0000-0003-0011-7957
dc.identifier.orcidhttps://orcid.org/0000-0003-4756-1115
dc.identifier.orcidhttps://orcid.org/0000-0001-8515-0654
dc.identifier.orcidhttps://orcid.org/0000-0001-7498-2121
dc.identifier.orcidhttps://orcid.org/0000-0002-4095-5173
dc.identifier.orcidhttps://orcid.org/0000-0003-3544-2821
dc.identifier.orcidhttps://orcid.org/0000-0001-9059-6394
dc.identifier.orcidhttps://orcid.org/0000-0001-8993-9353
dc.identifier.orcidhttps://orcid.org/0000-0002-1240-7612
dc.identifier.orcidhttps://orcid.org/0000-0002-8562-0078
dc.identifier.orcidhttps://orcid.org/0000-0002-9925-0581
dc.identifier.pmid37631286
dc.identifier.researcheridACO-5600-2022
dc.identifier.researcheridHNJ-0615-2023
dc.identifier.researcheridIZE-4397-2023
dc.identifier.researcheridAAW-3848-2020
dc.identifier.researcheridHLQ-4259-2023
dc.identifier.researcheridAAV-1672-2020
dc.identifier.researcheridHLX-3048-2023
dc.identifier.rorhttps://ror.org/001b4cb05
dc.identifier.rorhttps://ror.org/01hrxxx24
dc.identifier.rorhttps://ror.org/029ycp228
dc.identifier.rorhttps://ror.org/054rm6z62
dc.identifier.rorhttps://ror.org/0166e9x11
dc.identifier.rorhttps://ror.org/05h6yvy73
dc.identifier.scopusauthorid57209292648
dc.identifier.scopusauthorid56951201800
dc.identifier.scopusauthorid57219897333
dc.identifier.scopusauthorid57217679819
dc.identifier.scopusauthorid58554891600
dc.identifier.scopusauthorid57213824509
dc.identifier.scopusauthorid57216660307
dc.identifier.scopusauthorid8108126000
dc.identifier.scopusauthorid57697397700
dc.identifier.scopusauthorid58554756500
dc.identifier.scopusauthorid55794064800
dc.identifier.scopusauthorid58555027100
dc.identifier.scopusauthorid7801468635
dc.identifier.urihttps://repositorio.udla.cl/handle/udla/1337
dc.language.isoeng
dc.publisherMDPI AG
dc.relation.fundingFondo Interno VRII-UNAP, (VRIIP0056-21)
dc.relation.fundingProyecto Canon Minero, (0262–2021/UNT)
dc.relation.fundingProyecto Canon Minero (Peril) [0262-2021/UNT]
dc.relation.fundingFondo Interno VRII-UNAP (Chile) [VRIIP0056-21]
dc.relation.isindexedbyWeb of Science
dc.relation.issn1999-4923
dc.rightsCreative Commons Attribution 4.0 International
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourcePHARMACEUTICS
dc.source.urihttps://doi.org/10.3390/pharmaceutics15082072
dc.subjectValeriana pilosa
dc.subjectantispasmodic effect
dc.subjectessential oil
dc.subjectmolecular docking
dc.subject.oecd13 Ciencias Médicas y de la Salud
dc.subject.oecd23.1 Medicina Básica
dc.subject.oecd33.1.5 Farmacología y Farmacia
dc.titleAntispasmodic Effect of Valeriana pilosa Root Essential Oil and Potential Mechanisms of Action: Ex Vivo and In Silico Studies
dc.title.alternativeAntispasmodic Effect of Valeriana pilosa Root Essential Oil and Potential Mechanisms of Action: Ex Vivo and In Silico Studies.
dc.typejournal article
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.udla.catalogadorCBM
oaire.citation.issue8
oaire.citation.titlePHARMACEUTICS
oaire.citation.volume15
udla.curacion.controljmvg
udla.oecd.area3 Ciencias Médicas y de la Salud
udla.oecd.discipline3.1.5 Farmacología y Farmacia
udla.oecd.subarea3.1 Medicina Básica

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
177.pdf
Size:
5.31 MB
Format:
Adobe Portable Document Format

Collections